EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Guidewire–bile duct angle as a determinant of stent delivery success in EUS-guided hepaticogastrostomy: a prospective double-lumen dilator cohort with propensity score-matched historical controls

Naoto Aoyama, Takeshi Ogura iD, Yoshitaro Yamamoto, Saori Ueno, Atsushi Okuda, Nobu Nishioka, Junichi Nakamura, Nobuhiro Hattori, Kimi Bessho, Takafumi Kanadani, Nga Nguyen Trong, Ly Kim Chhun und 4 weitere

Therapeutic Advances in Gastroenterology · 2026-07 · 19

DOI: 10.1177/17562848261470177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Gastroenterology, online erschienen am 30.07.2026. Verfasst von Naoto Aoyama und 15 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Failure of stent delivery remains a major technical limitation of endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS), often necessitating additional tract dilation and increasing procedural complexity and cost.

Objectives

The aim of this study was to evaluate whether the guidewire–bile duct angle is associated with stent delivery success in EUS-HGS, and to explore whether a double-lumen dilator (DLD) is associated with procedural improvement consistent with an angle-mediated mechanism rather than direct mechanical advantage.

Design

Prospective observational study with a propensity score-matched historical control.

Methods

This was a prospective single-arm observational study of patients undergoing EUS-HGS using a DLD, compared with a propensity score-matched historical (retrospective) cohort that underwent conventional dilation. The main outcome was successful stent delivery without additional tract dilation.

Results

A total of 25 patients in the DLD group were compared with 25 matched controls. Successful stent delivery without additional dilation was significantly higher in the DLD group than in the conventional group (92% vs 48%, p = 0.001). The guidewire–bile duct angle measured immediately before stent delivery-system insertion was significantly larger in the DLD group than in the conventional group (153.4° vs 123.3°, p < 0.001). On multivariable analysis, a larger guidewire–bile duct angle remained independently associated with successful stent delivery without additional tract dilation (odds ratio per 10-degree increase, 5.49; 95% confidence interval, 2.79–10.83; p < 0.001), whereas DLD use itself was not independently associated with success after adjustment for angle. Device-related costs were lower in the DLD group due to reduced need for additional dilation. The guidewire–bile duct angle showed excellent apparent discrimination in this cohort, with an exploratory threshold of 126° (AUC 0.969), requiring external validation before clinical implementation.

Conclusion

In conclusion, the improvement associated with DLD use was consistent with an angle-mediated mechanism rather than a direct effect of dilation force; these findings should be regarded as hypothesis-generating mechanistic evidence rather than mechanistic proof.

Schlagwörter

Stichwörter der Autor:innen

ERCPEUS-HGSbile peritonitisdilatorendoscopic ultrasound-guided hepaticogastrostomy

Autor:innen und Institutionen

  • 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
  • Pancreatobiliary Advanced Medical Center, Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan.
  • Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, Takatsukishi, Osaka, Japan.
  • Pancreatobiliary Advanced Medical Center, Osaka Medical and Pharmaceutical University Hospital, Takatsukishi, Osaka, Japan.
  • Gastroenterology, Trong Nam Cancer Hospital, Ha Noi, Viet Nam.
  • Gastroenterology, Calmette Hospital, Phnom Penh, Cambodia.

ORCID-Profile: Takeshi Ogura

Zitieren

APA

Aoyama, N., Ogura, T., Yamamoto, Y., Ueno, S., Okuda, A., Nishioka, N., Nakamura, J., Hattori, N., Bessho, K., Kanadani, T., Trong, N. N., Chhun, L. K., Aboelezz, A. F., Liao, Y. J., Liao, S. C., & Nishikawa, H. (2026). Guidewire–bile duct angle as a determinant of stent delivery success in EUS-guided hepaticogastrostomy: a prospective double-lumen dilator cohort with propensity score-matched historical controls. Therapeutic Advances in Gastroenterology, 19. https://doi.org/10.1177/17562848261470177

Vancouver

Aoyama N, Ogura T, Yamamoto Y, Ueno S, Okuda A, Nishioka N, et al. Guidewire–bile duct angle as a determinant of stent delivery success in EUS-guided hepaticogastrostomy: a prospective double-lumen dilator cohort with propensity score-matched historical controls. Therapeutic Advances in Gastroenterology. 2026;19. doi:10.1177/17562848261470177

BibTeX
@article{Aoyama2026,
  author = {Aoyama, Naoto and Ogura, Takeshi and Yamamoto, Yoshitaro and Ueno, Saori and Okuda, Atsushi and Nishioka, Nobu and Nakamura, Junichi and Hattori, Nobuhiro and Bessho, Kimi and Kanadani, Takafumi and Trong, Nga Nguyen and Chhun, Ly Kim and Aboelezz, Ahmad F and Liao, Yi-Jun and Liao, Szu-Chia and Nishikawa, Hiroki},
  title = {Guidewire–bile duct angle as a determinant of stent delivery success in EUS-guided hepaticogastrostomy: a prospective double-lumen dilator cohort with propensity score-matched historical controls},
  journal = {Therapeutic Advances in Gastroenterology},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562848261470177}
}
Kostenlos starten →